OSI PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 39216
 
  
 
C07D HETEROCYCLIC COMPOUNDS 20142
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 10115
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8159
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
  
 
C07K PEPTIDES 4132
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 392
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8575164 Combination cancer therapyFeb 25, 08Nov 05, 13[A61K, A01N]
8481733 Substituted imidazopyr- and imidazotri-azinesMay 19, 09Jul 09, 13[A61K, C07D, A61P]
8093011 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitorsMar 16, 06Jan 10, 12[G01N]
8062838 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitorsSep 19, 06Nov 22, 11[C12Q, G01N]
8022206 Furo[3,2-C]pyridinesFeb 06, 09Sep 20, 11[C07D]
7951405 Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitorJun 03, 05May 31, 11[A61K]
7943767 Fused bicyclic mTOR inhibitorsNov 20, 09May 17, 11[A61K, C07D, A61P]
7939272 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitorsSep 29, 08May 10, 11[G01N]
7923555 Fused bicyclic mTor inhibitorsDec 02, 08Apr 12, 11[A61K, C07D, A61P]
7879566 Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of diseaseMar 17, 09Feb 01, 11[G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8642834 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formationExpiredFeb 26, 10Feb 04, 14[A61K, G01N, A01K, A61P]
8557814 mTOR inhibitor salt formsExpiredMar 18, 09Oct 15, 13[A61K, C07D]
8513415 -pyrazine-methylaminesExpiredApr 19, 10Aug 20, 13[C07D]
2012/0220,595 Deuterated Tyrosine Kinase InhibitorsAbandonedNov 11, 10Aug 30, 12[A61K, C07D, A61P]
2012/0108,812 PROCESS FOR SUBSTITUTED 3-AMINO-5-OXO-4,5-DIHYDRO-[1,2,4]TRIAZINESAbandonedJul 08, 10May 03, 12[C07D]
2012/0064,072 Combination Cancer Therapy Comprising Administration of an EGFR Inhibitor and an IGF-1R InhibitorAbandonedMar 18, 10Mar 15, 12[A61K, A61P]
2011/0275,644 BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORSAbandonedMar 03, 11Nov 10, 11[A61K, C12Q, A61P]
8048621 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitorsExpiredSep 29, 08Nov 01, 11[C12Q, G01N]
2011/0217,309 BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORSAbandonedMar 03, 11Sep 08, 11[A61K, C12Q, A61P]
2011/0190,496 FUSED BICYCLIC mTOR INHIBITORSAbandonedApr 13, 11Aug 04, 11[C07F, C07D]
2011/0171,124 In situ methods for monitoring the EMT status of tumor cells in vivoAbandonedFeb 24, 10Jul 14, 11[A61K, G01N, A61P]
7951549 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formationExpiredMar 06, 09May 31, 11[C12Q, G01N]
2011/0046,144 IMIDAZOPYRAZINOL DERIVATIVES FOR THE TREATMENT OF CANCERSAbandonedJan 16, 09Feb 24, 11[A61K, C07D, A61P]
2010/0286,155 ADRENOCORTICAL CARCINOMA TREATMENTAbandonedMay 07, 10Nov 11, 10[A61K, A61P]
7829717 (Arylamidoaryl)squaramide compoundsExpiredSep 15, 05Nov 09, 10[A61K, C07D]
7767673 N-substituted imidazopyridine c-Kit inhibitorsExpiredSep 12, 08Aug 03, 10[A61K, C07D]
7662844 Naphthylene derivatives as cytochrome P450 inhibitorsExpiredJul 12, 04Feb 16, 10[A61K, C07D]
7659274 Unsaturated mTOR inhibitorsExpiredJan 24, 07Feb 09, 10[A61K]
7648987 Bicyclic protein kinase inhibitorsExpiredDec 04, 06Jan 19, 10[A61K, C07D]
7645754 selective antagonist compounds, their synthesis and useExpiredJun 19, 07Jan 12, 10[A61K, C07D, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.